news 2020

« BACK

Pharmacology



Results 1 - 20 of 475.
1 2 3 4 5 ... 24 Next »


Life Sciences - Pharmacology - 23.12.2020
Genetic Engineering without Unwanted Side-Effects Helps Fight Parasites
Genetic Engineering without Unwanted Side-Effects Helps Fight Parasites
Modified CRISPR-Cas9 gene editing scissors are enabling researchers at UZH to make alterations to the genetic material of single-cell organisms that are indistinguishable from natural mutations. This method is making it possible to develop a (harmless) experimental live vaccine for the widespread parasite Toxoplasma gondii.

Health - Pharmacology - 21.12.2020
Large study in UK NHS labs shows gold-standard accuracy of Oxford Nanopore's COVID-19 test LamPORE for both symptomatic and asymptomatic patients
Large study in UK NHS labs shows gold-standard accuracy of Oxford Nanopore’s COVID-19 test LamPORE for both symptomatic and asymptomatic patients
A study of more than 23,000 samples carried out by teams across the UK shows Oxford Nanopore's COVID-19 test, LamPORE, is highly accurate for the detection of SARS-CoV-2, in both symptomatic and asymptomatic population settings. The study was performed on both swab and saliva samples across four NHS sites, showing very high LamPORE test accuracy, as follows: These data support the use of LamPORE for testing of both symptomatic people, and those without symptoms.

Health - Pharmacology - 18.12.2020
AI-supported test predicts eye disease three years before symptoms
A pioneering new eye test, developed by scientists at UCL in collaboration with the Western Eye Hospital, London, may predict wet AMD, a leading cause of severe sight loss, three years before symptoms develop. Researchers hope their test could be used to identify the disease early enough so that treatment can effectively prevent any vision loss.

Health - Pharmacology - 17.12.2020
Breathing rate predicts therapeutic benefits for heart patients
Discovering a forgotten biosignal Conditions causing arrhythmia are among the most common cardiac conditions. A study headed by Prof. Georg Schmidt of the Technical University of Munich (TUM) has demonstrated for the first time that the nocturnal respiratory rate can help with an important prediction: It is an indicator of whether a defibrillator will help to extend the life of patients with arrhythmia.

Pharmacology - Health - 17.12.2020
Improving vaccination rates by dispelling mistrust and conspiracy
A leading University of Queensland academic is using his research to improve vaccination rates across the country. Dr Tom Aechtner from UQ's School of Historical and Philosophical Inquiry has launched the world's first Massive Open Online Couse (MOOC), AVAXX101 , dedicated to anti-vaccination and vaccine hesitancy.

Health - Pharmacology - 17.12.2020
New drug to combat global killer sepsis
New drug to combat global killer sepsis
A promising new drug to combat sepsis has been developed by researchers at The Australian National University (ANU), potentially saving millions of lives each year. ANU Professor Christopher Parish and his team have been working on the drug for more than 10 years, with the drug being developed from compounds originally designed to fight cancer.

Pharmacology - Health - 16.12.2020
Common drug for build-up of blood following head injury worse than placebo
Common drug for build-up of blood following head injury worse than placebo
A commonly-used treatment for chronic subdural haematoma - the build-up of 'old' blood in the space between the brain and the skull, usually as a result of minor head injury - could lead to a worse outcome than receiving no medication, suggests new research from the University of Cambridge. Our trial sought to determine if dexamethasone should be offered routinely to all patients with chronic subdural haematoma or if its use should be abandoned.

Health - Pharmacology - 16.12.2020
Study highlights stark inequality in survival after cardiac surgery between paying and NHS patients
Study highlights stark inequality in survival after cardiac surgery between paying and NHS patients
A new study has revealed paying patients are 20 per cent less likely to die or develop major complications, such as reintervention or stroke, after cardiac surgery than NHS patients - findings researchers say cannot be explained by socioeconomic factors alone. The study, led by academics at the University of Bristol, looked at the data of over 280,000 patients who underwent adult cardiac surgery over a ten-year period from 2009 to 2018 at 31 NHS cardiac units in England.

Health - Pharmacology - 16.12.2020
Digipredict digital twin will predict the evolution of Covid-19
Digipredict digital twin will predict the evolution of Covid-19
Under a cross-disciplinary program spearheaded by EPFL, scientists will develop an AI-based system that can predict whether Covid-19 patients will develop severe cardiovascular complications and, in the longer term, detect the likely onset of inflammatory disease. Covid-19 comes with a range of symptoms - from a sore throat and the loss of taste to more serious ones like lung failure.

Life Sciences - Pharmacology - 16.12.2020
New use for an old drug: How does ketamine combat depression?
A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The discovery could lead to better and safer treatments for certain patients suffering from major depression.

Health - Pharmacology - 14.12.2020
Remdesivir likely to be highly effective antiviral against SARS-CoV-2 for some patients
Remdesivir likely to be highly effective antiviral against SARS-CoV-2 for some patients
The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing , the researchers describe giving the drug to a patient with COVID-19 and a rare immune disorder, and observing a dramatic improvement in his symptoms and the disappearance of the virus.

Life Sciences - Pharmacology - 14.12.2020
RNA basic building block produced biocatalytically for the first time
RNA basic building block produced biocatalytically for the first time
Researchers from TU Graz and acib succeed in the first enzyme-driven biocatalytic synthesis of nucleic acid building blocks. This facilitates the development of antiviral agents and RNA-based therapeutics. Due to the COVID 19 pandemic and the associated intensive search for therapeutics and vaccines, the chemical substance class of nucleosides is experiencing an enormous increase in interest.

Health - Pharmacology - 11.12.2020
A data-driven approach to identify risk profiles and protective drugs in COVID-19
A study performed in Ticino between Ente Ospedaliero Cantonale (EOC), USI UniversitÓ della Svizzera italiana and UniversitÓ Vita-Salute San Raffaele (UniSR, Milan, Italy) has shown how drugs against hypertension can reduce by more than 60% the risk of mortality in COVID-19 patients. The multidisciplinary study concerned 576 patients admitted to the EOC during the first wave of the epidemic, and was published in the prestigious journal Proceedings of the National Academy of Sciences (PNAS).

Health - Pharmacology - 11.12.2020
New study to evaluate antibiotic use in COVID-19 hospital patients
A group of researchers is to evaluate whether a simple blood test for bacterial infection could help to reduce the use of antibiotics in patients with COVID-19. A procalcitonin blood test (PCT) is used in hospitals to distinguish between bacterial and viral infections and guide antibiotic treatment.

Health - Pharmacology - 11.12.2020
New treatment could spare early-stage rectal cancer patients life-altering side effects
New treatment could spare early-stage rectal cancer patients life-altering side effects
A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer, giving patients a better quality of life with fewer life-altering side effects, results from a pilot study show. Results from the TREC trial show that a combination of local keyhole surgery and radiotherapy, rather than major surgery that removes the whole rectum, prevents debilitating side effects, such as diarrhoea, or the need for a permanent colostomy bag.

Pharmacology - Health - 08.12.2020
UCLA nursing professor shares her experience as a subject in COVID-19 vaccine trial
In August, Kristen Choi, a UCLA assistant professor of nursing, thought about how important it would be to participate in the testing of one of the new COVID-19 vaccines. So she stepped out of her usual role of conducting research and volunteered to become a study subject. Choi describes her experience as a participant in the trial for a vaccine being developed by Pfizer and BioNTech in a perspective published in JAMA Internal Medicine.

Health - Pharmacology - 08.12.2020
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about the trial, please visit theá Oxford COVID-19 vaccine web hub áor visit theá COVID-19 trial website .

Pharmacology - Health - 08.12.2020
Better education needed to give patients improved understanding of gene therapies, new review highlights
Better education needed to give patients improved understanding of gene therapies, new review highlights
A new review of research bringing together patient, carer and public views of cell and gene therapies has highlighted a need for appropriate education to better inform people including how clinical trials work and the risks and benefits of various treatments. Over the last decade, new cell, gene and tissue-engineered therapies have been developed to treat various cancers, inherited diseases and some chronic conditions.

Health - Pharmacology - 04.12.2020
Analysis finds four repurposed antiviral drugs have little or no effect on patients hospitalised for COVID-19
Repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon - to treat COVID-19 appear to have little or no effect on patients hospitalised for the disease, in terms of overall mortality, initiation of ventilation and duration of hospital stay. The interim findings from the WHO Solidarity trial, published in the New England Journal of Medicine (NEJM), followed 11,266 adults at 405 hospitals in 30 countries.

Health - Pharmacology - 01.12.2020
Deciphering the energetic code of cells for better anticancer therapies
Deciphering the energetic code of cells for better anticancer therapies
A procedure that may help personalise anticancer therapies has just been developed by the CNRS, INSERM, and Aix-Marseille University scientists at the Centre d'Immunologie de Marseille-Luminy, in association with colleagues from the University of California San Francisco and the Marseille Public University Hospital System (AP-HM), with support from Cancerop˘le Provence-Alpes-C˘te d'Azur.
1 2 3 4 5 ... 24 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |